Key Segmentation
By Product Type
-
Ultra-Low Temperature Freezers
-
Deep Freezers
-
Cryogenic Freezers
-
Blood Bank and Chromatography Refrigerators
By Cabinet Design
-
Upright
-
Chest
By Temperature Range
-
Below -80°C
-
-40°C to -80°C
-
-20°C to -40°C
By Application
-
Biological Sample Storage
-
Vaccine Storage
-
Genetic and Genomic Research
-
Blood Banking
By End User
-
Pharmaceutical and Biotechnology Companies
-
Hospitals and Blood Banks
-
Academic and Research Institutes
-
Cell and Tissue Banks
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Thermo Fisher Scientific Inc., Haier Biomedical, PHC Holdings Corporation, Eppendorf SE, and Helmer Scientific, among other cold storage equipment manufacturers.
Continued development of energy-efficient, low global-warming-potential refrigeration technology and continued adoption of modular, distributed storage architecture represent the primary opportunities.
Growth is primarily driven by increasing demand for biopharmaceuticals, combined with rising investments in healthcare infrastructure worldwide.
By Product Type, Ultra-Low Temperature Freezers dominated the market with a 44.80% share in 2025, reflecting their essential role in biological sample and therapy storage.
North America dominated the market with a 34.90% share in 2025, supported by substantial biopharmaceutical manufacturing capacity and extensive research infrastructure.
